{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:38:36Z","timestamp":1788968316292,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ccl.2021.04.009","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T22:13:21Z","timestamp":1625782401000},"page":"365-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems"],"prefix":"10.1016","volume":"39","author":[{"given":"Davide","family":"Agnoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"SUPPL. 1","key":"10.1016\/j.ccl.2021.04.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1906","article-title":"A\u00a0concise history of gout and hyperuricemia and their treatment","volume":"8","author":"Nuki","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40674-015-0012-9","article-title":"Gout and hyperuricemia: an historical perspective","volume":"1","author":"MacKenzie","year":"2015","journal-title":"Curr Treat Options Rheumatol"},{"key":"10.1016\/j.ccl.2021.04.009_bib4","series-title":"Harrison\u2019s principles of internal medicine","first-page":"3181","article-title":"Disorders of purine and pyrimidine metabolism","author":"Burns","year":"2012"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-013-0400-9","article-title":"The crystallization of monosodium urate","volume":"16","author":"Martillo","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"10.1016\/j.ccl.2021.04.009_bib6","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1096\/fasebj.6.8.1592211","article-title":"Antibodies against crystals","volume":"6","author":"Kam","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.ccl.2021.04.009_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/TCRM.S232033","article-title":"Uric acid and arterial stiffness","volume":"16","author":"Albu","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00163854","article-title":"Two independent mutational events in the loss of urate oxidase during hominoid evolution","volume":"34","author":"Wu","year":"1992","journal-title":"J\u00a0Mol Evol"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mehy.2008.01.017","article-title":"The planetary biology of ascorbate and uric acid and their relationship with the epidemic of obesity and cardiovascular disease","volume":"71","author":"Johnson","year":"2008","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jhev.1997.0184","article-title":"Hominoid evolution and environmental change in the Neogene of Europe: a European science foundation network","volume":"34","author":"Agust\u00ed","year":"1998","journal-title":"J\u00a0Hum Evol"},{"key":"10.1016\/j.ccl.2021.04.009_bib11","first-page":"295","article-title":"The evolution of obesity: insights from the mid-Miocene","volume":"121","author":"Johnson","year":"2010","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib12","first-page":"487","article-title":"Physiological functions and pathogenic potential of uric acid: a review","volume":"8","author":"El Ridi","year":"2017","journal-title":"J\u00a0Adv Res"},{"issue":"11","key":"10.1016\/j.ccl.2021.04.009_bib13","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib14","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1253\/circj.CJ-14-1267","article-title":"Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia","volume":"79","author":"Sugihara","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.ccl.2021.04.009_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","author":"Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ccl.2021.04.009_bib16","doi-asserted-by":"crossref","first-page":"106565","DOI":"10.1016\/j.vph.2019.106565","article-title":"Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects","volume":"120","author":"Cortese","year":"2019","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib17","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/srep04554","article-title":"Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice","volume":"4","author":"Nomura","year":"2015","journal-title":"Sci Rep"},{"issue":"9\u201311","key":"10.1016\/j.ccl.2021.04.009_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1080\/15257770600890772","article-title":"Purine catabolism in advanced carotid artery plaque","volume":"25","author":"Felici","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib19","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1096\/fj.201901148R","article-title":"Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding","volume":"33","author":"Ko","year":"2019","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2459\/JCM.0b013e328360940b","article-title":"Age-adjusted level of circulating elastin as a cardiovascular risk factor in medical check-up individuals","volume":"15","author":"Yamanaka","year":"2014","journal-title":"J\u00a0Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.ccl.2021.04.009_bib21","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1096\/fj.14-267393","article-title":"ILr1\u03b2 production is dependent on the activation of purinergic receptors and NLRP3 pathway in human macrophages","volume":"29","author":"Gicquel","year":"2015","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.ccl.2021.04.009_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","article-title":"Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity","volume":"40","author":"Watanabe","year":"2002","journal-title":"Hypertension"},{"issue":"2890","key":"10.1016\/j.ccl.2021.04.009_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(02)46030-8","article-title":"On chronic bright\u2019s disease, and its essential symptoms","volume":"113","author":"Mahomed","year":"1879","journal-title":"Lancet"},{"issue":"1467","key":"10.1016\/j.ccl.2021.04.009_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bmj.1.1467.288","article-title":"On uric acid and arterial tension","volume":"1","author":"Haig","year":"1889","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.ccl.2021.04.009_bib25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1291\/hypres.27.835","article-title":"Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan","volume":"27","author":"Nagahama","year":"2004","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib27","doi-asserted-by":"crossref","first-page":"e114259","DOI":"10.1371\/journal.pone.0114259","article-title":"Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.ccl.2021.04.009_bib28","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.2174\/138161205774913200","article-title":"Serum uric acid and risk of coronary heart disease","volume":"11","author":"Wannamethee","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib29","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"Mazzali","year":"2001","journal-title":"Hypertension"},{"issue":"6 51\u20136","key":"10.1016\/j.ccl.2021.04.009_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/ajprenal.00283.2001","article-title":"Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism","volume":"282","author":"Mazzali","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra011078","article-title":"Subtle acquired renal injury as a mechanism of salt-sensitive hypertension","volume":"346","author":"Johnson","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib32","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","article-title":"Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction","volume":"28","author":"Yu","year":"2010","journal-title":"J\u00a0Hypertens"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib33","first-page":"972","article-title":"Incidence of hyperuricemia in 400 hypertensive patients","volume":"24","author":"Kinsey","year":"1961","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-8703(72)90331-6","article-title":"The incidence of hypertension and associated factors: the Israel ischemic heart disease study","volume":"84","author":"Kahn","year":"1972","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2021.04.009_bib35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archinte.1973.03650090077014","article-title":"Serum uric acid - its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia","volume":"132","author":"Klein","year":"1973","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.HYP.0000254480.64564.b6","article-title":"Hyperuricemia and incidence of hypertension among men without metabolic syndrome","volume":"49","author":"Krishnan","year":"2007","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","article-title":"Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation","volume":"42","author":"Masuo","year":"2003","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1024600905574","article-title":"Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers","volume":"18","author":"Nakanishi","year":"2002","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","article-title":"Uric acid and the development of hypertension: the normative aging study","volume":"48","author":"Perlstein","year":"2006","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.ccl.2021.04.009_bib40","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1096\/fj.13-243634","article-title":"Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids","volume":"28","author":"Cicerchi","year":"2014","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib41","doi-asserted-by":"crossref","first-page":"e56864","DOI":"10.1371\/journal.pone.0056864","article-title":"High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies","volume":"8","author":"Lv","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ccl.2021.04.009_bib42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/ijms17081248","article-title":"Association of serum uric acid concentration with diabetic retinopathy and albuminuria in Taiwanese patients with type 2 diabetes mellitus","volume":"17","author":"Liang","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.ccl.2021.04.009_bib43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/HJH.0000000000000701","article-title":"Serum uric acid and the risk of cardiovascular and renal disease","volume":"33","author":"Borghi","year":"2015","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","article-title":"Prevalence of the metabolic syndrome in individuals with hyperuricemia","volume":"120","author":"Choi","year":"2007","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.ccl.2021.04.009_bib45","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10654-013-9829-4","article-title":"Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population","volume":"28","author":"Dai","year":"2013","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/09513590.2016.1214261","article-title":"The relationship between serum uric acid and metabolic syndrome in premenopausal and postmenopausal women in the Jinchang Cohort","volume":"33","author":"He","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40200-015-0200-z","article-title":"Association between serum uric acid level and metabolic syndrome components","volume":"14","author":"Nejatinamini","year":"2015","journal-title":"J\u00a0Diabetes Metab Disord"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00380-013-0386-2","article-title":"Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population","volume":"29","author":"Oda","year":"2014","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12872-015-0059-4","article-title":"The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study","volume":"15","author":"Tian","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib50","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","article-title":"Uric acid and the development of metabolic syndrome in women and men","volume":"57","author":"Sui","year":"2008","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.ccl.2021.04.009_bib51","doi-asserted-by":"crossref","first-page":"e78206","DOI":"10.1371\/journal.pone.0078206","article-title":"Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a meta-analysis","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ccl.2021.04.009_bib52","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/clc.23266","article-title":"The association between hyperuricemia and coronary artery calcification development: a systematic review and meta-analysis","volume":"42","author":"Liang","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ccl.2021.04.009_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cca.2018.06.002","article-title":"Uric acid in aortic dissection: a meta-analysis","volume":"484","author":"Li","year":"2018","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1515\/cclm-2015-0523","article-title":"Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis","volume":"54","author":"Braga","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5603\/CJ.2018.0116","article-title":"Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk","volume":"25","author":"Borghi","year":"2018","journal-title":"Cardiol J"},{"issue":"3","key":"10.1016\/j.ccl.2021.04.009_bib56","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0020076","article-title":"Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis","volume":"2","author":"Wheeler","year":"2005","journal-title":"Plos Med"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2013.08.023","article-title":"Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies","volume":"231","author":"Zhao","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3899\/jrheum.121231","article-title":"Treatment of asymptomatic hyperuricemia and prevention of vascular disease: a decision analytic approach","volume":"41","author":"Akkineni","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.ccl.2021.04.009_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000360520","article-title":"Allopurinol as a kidney-protective, cardioprotective, and antihypertensive agent: hype or reality?","volume":"37","author":"Kanbay","year":"2014","journal-title":"Blood Purif"},{"key":"10.1016\/j.ccl.2021.04.009_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijcard.2017.10.045","article-title":"Serum uric acid levels are associated with cardiovascular risk score: a post hoc analysis of the EURIKA study","volume":"253","author":"Borghi","year":"2018","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2021.04.009_bib62","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1742-1241.2009.02263.x","article-title":"The association between serum uric acid level and coronary artery disease","volume":"64","author":"Sinan Deveci","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib63","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.STR.0000221716.55088.d4","article-title":"Uric acid is a risk factor for myocardial infarction and stroke","volume":"37","author":"Bos","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ccl.2021.04.009_bib64","doi-asserted-by":"crossref","first-page":"19520","DOI":"10.1038\/srep19520","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib65","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2001.114367","article-title":"Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance","volume":"141","author":"Doehner","year":"2001","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10741-019-09869-z","article-title":"Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure","volume":"25","author":"Borghi","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ccl.2021.04.009_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2015.08.089","article-title":"Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications","volume":"213","author":"Doehner","year":"2016","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2013.11.051","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies","volume":"232","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib69","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jch.12855","article-title":"Hyperuricemia and the prognosis of hypertensive patients: a systematic review and meta-analysis","volume":"18","author":"Qin","year":"2016","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib70","article-title":"Sex-specific relationship between serum uric acid and risk of stroke: a dose-response meta-analysis of prospective studies","volume":"6","author":"Zhong","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib71","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/0003319707303444","article-title":"Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial","volume":"58","author":"Baker","year":"2007","journal-title":"Angiology"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib72","first-page":"190","article-title":"A\u00a0randomized controlled trial of allopurinol in patients with peripheral arterial disease","volume":"32","author":"Robertson","year":"2016","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib73","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.ajkd.2010.01.019","article-title":"Association of uric acid with change in kidney function in healthy Normotensive individuals","volume":"56","author":"Bellomo","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.ccl.2021.04.009_bib74","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1093\/ndt\/gfq740","article-title":"Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study","volume":"26","author":"Ben-Dov","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ccl.2021.04.009_bib75","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1681\/ASN.2004030208","article-title":"Risk factors for development of decreased kidney function in a southeast asian population: a 12-year cohort study","volume":"16","author":"Domrongkitchaiporn","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib76","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/ndt\/gfu256","article-title":"A\u00a0slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population","volume":"29","author":"Kamei","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib77","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ajh\/7.12.1035","article-title":"Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension","volume":"7","author":"Sweet","year":"1994","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.ccl.2021.04.009_bib78","doi-asserted-by":"crossref","first-page":"e76827","DOI":"10.1371\/journal.pone.0076827","article-title":"Serum uric acid and chronic kidney disease: the role of hypertension","volume":"8","author":"Sedaghat","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib79","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.2007101075","article-title":"Uric acid and incident kidney disease in the community","volume":"19","author":"Weiner","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccl.2021.04.009_bib80","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-0227","article-title":"High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up","volume":"33","author":"Ficociello","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/dc11-1346","article-title":"Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function","volume":"35","author":"Zoppini","year":"2012","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.ccl.2021.04.009_bib82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","article-title":"Relationship of uric acid with progression of kidney disease","volume":"50","author":"Chonchol","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archinternmed.2008.605","article-title":"Risk factors for end-stage renal disease","volume":"169","author":"Hsu","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib84","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0272-6386(04)00934-5","article-title":"Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort","volume":"44","author":"Iseki","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.ccl.2021.04.009_bib85","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1600-6143.2011.03613.x","article-title":"Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis","volume":"11","author":"Haririan","year":"2011","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.ccl.2021.04.009_bib86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/TP.0b013e3181c73c18","article-title":"The independent association between serum uric acid and graft outcomes after kidney transplantation","volume":"89","author":"Haririan","year":"2010","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.ccl.2021.04.009_bib87","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.amjhyper.2007.08.010","article-title":"Mild hyperuricemia and subclinical renal damage in untreated primary hypertension","volume":"20","author":"Viazzi","year":"2007","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-016-0379-z","article-title":"Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies","volume":"16","author":"Zuo","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12872-019-1215-z","article-title":"Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"19","author":"Rahimi-Sakak","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"10.1016\/j.ccl.2021.04.009_bib90","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/art.24612","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis","volume":"61","author":"Kim","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib91","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1751-7133.2011.00200.x","article-title":"Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis","volume":"17","author":"Tamariz","year":"2011","journal-title":"Congest Heart Fail"},{"issue":"8","key":"10.1016\/j.ccl.2021.04.009_bib92","doi-asserted-by":"crossref","first-page":"e14525","DOI":"10.1097\/MD.0000000000014525","article-title":"Prognostic value of serum uric acid in patients with acute heart failure: a meta-analysis","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib93","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","article-title":"Uric acid and risk of heart failure: a systematic review and meta-analysis","volume":"16","author":"Huang","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib94","doi-asserted-by":"crossref","first-page":"e13074","DOI":"10.1111\/eci.13074","article-title":"Prognostic value of hyperuricemia in patients with acute coronary syndrome: a meta-analysis","volume":"49","author":"He","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ccl.2021.04.009_bib95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.10.006","article-title":"Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis","volume":"254","author":"Wang","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ccl.2021.04.009_bib96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12882-018-1143-7","article-title":"Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis","volume":"20","author":"Luo","year":"2019","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2021.04.009_bib97","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2047487313514895","article-title":"Increased cardiovascular mortality associated with gout: a systematic review and meta-analysis","volume":"22","author":"Clarson","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2021.04.009_bib98","doi-asserted-by":"crossref","first-page":"107409","DOI":"10.1016\/j.jdiacomp.2019.07.006","article-title":"Serum uric acid as a risk factor of all-cause mortality and cardiovascular events among type 2 diabetes population: meta-analysis of correlational evidence","volume":"33","author":"Shao","year":"2019","journal-title":"J\u00a0Diabet Complications"},{"key":"10.1016\/j.ccl.2021.04.009_bib99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejim.2020.01.001","article-title":"Management of hyperuricemia in asymptomatic patients: a critical appraisal","volume":"74","author":"Brucato","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ccl.2021.04.009_bib100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2147\/OTT.S103864","article-title":"Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase","volume":"10","author":"Alakel","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ccl.2021.04.009_bib101","article-title":"Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients","author":"Cicero","year":"2020","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.ccl.2021.04.009_bib102","article-title":"Pharmacotherapy for hyperuricaemia in hypertensive patients","author":"Gois","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ccl.2021.04.009_bib103","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0003319719897509","article-title":"Effect of uric acid-lowering agents on cardiovascular outcome in patients with heart failure: a systematic review and meta-analysis of clinical studies","volume":"71","author":"Kanbay","year":"2020","journal-title":"Angiology"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865121000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:54:21Z","timestamp":1760007261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865121000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0733865121000321"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2021.04.009","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2021.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}